Family Model Diabetes Self-Management Education in Faith-Based Organizations in the Republic of the Marshall Islands

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Health disparities in the Republic of the Marshall Islands are striking, with extremely high rates of type 2 diabetes. Documented prevalence of type 2 diabetes in the Marshall Islands ranges from 20%-50%.This is significantly higher than the global (8.5%) and United States (11%) prevalence. Diabetes doubles the risk of heart disease; is the leading cause of kidney failure, lower limb amputation, and acquired blindness; and reduces life expectancy by as much as 15 years. Diabetes self-management education and support is critical for persons with diabetes. This study aims to conduct a cluster-randomized controlled trial using a wait-list control to evaluate the effectiveness of family model diabetes self-management education and support when delivered in faith-based organizations (i.e., churches) in Marshallese by trained community health workers. The study will be conducted with up to 288 participants with type 2 diabetes and up to 288 of their family members. The primary study outcome will be glycemic control as measured by HbA1c. Secondary biometric measures include: fasting glucose, weight, body mass index, and blood pressure. Survey data will be collected pre-intervention, immediately post-intervention, four months post-intervention, and 12 months post-intervention for the intervention arm of the study. The control arm of the study will have two pre-intervention data collections before beginning the intervention. Data will then be collected from the control group immediately post-intervention, four months post-intervention, and 12 months post intervention.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• self-reported Marshallese

• 18 years of age or older

• have type 2 diabetes (defined as having HbA1c equal to or greater than 6.5%)

• have at least one family member willing to take part in the study

Locations
United States
Arkansas
UAMS Institute for Community Health Innovation
RECRUITING
Springdale
Contact Information
Primary
Betsy O'Connor, MA
geoconnor@uams.edu
479-713-8000
Backup
Brett Rowland, MA
mbrowland@uams.edu
479-713-8000
Time Frame
Start Date: 2023-06-30
Estimated Completion Date: 2027-01
Participants
Target number of participants: 288
Treatments
Experimental: Intervention
Family model diabetes self-management education and support
Active_comparator: Wait-list Control
Family model diabetes self-management education and support
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: University of Arkansas

This content was sourced from clinicaltrials.gov

Similar Clinical Trials